In a patient with GCA and underlying cardiovascular risk factors, how do you approach antiplatelet therapy and statin use when starting tocilizumab as steroid sparing treatment?

I don't generally start ASA or other anti-platelet therapy for GCA without reviewing the need ( if any) with a cardiologist. Neither the ACR nor the BSR guidelines for vasculitis recommend these drugs for GCA.

On the other hand, managing lipids and blood pressure in all cases of GCA is essential. The...